Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Extracorporeal membrane oxygenation in the context of the 2009 H1N1 influenza A pandemic.

Sihler KC, Park PK.

Surg Infect (Larchmt). 2011 Apr;12(2):151-8. doi: 10.1089/sur.2010.082. Review.

PMID:
21545282
2.

[Extracorporeal lung support in patients with severe respiratory failure secondary to the 2010-2011 winter seasonal outbreak of influenza A (H1N1) in Spain].

Bonastre J, Suberviola B, Pozo JC, Guerrero JE, Torres A, Rodríguez A, Martín-Loeches I; SEMICYUC-CIBERES-REIPI working group.

Med Intensiva. 2012 Apr;36(3):193-9. doi: 10.1016/j.medin.2011.12.004. Epub 2012 Feb 15. Spanish.

3.

Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) severe respiratory failure in Japan.

Takeda S, Kotani T, Nakagawa S, Ichiba S, Aokage T, Ochiai R, Taenaka N, Kawamae K, Nishimura M, Ujike Y, Tajimi K; Committee of Crisis Control, the Japanese Society of Respiratory Care Medicine and Committee of Pandemic H1N1 Surveillance, the Japanese Society of Intensive Care Medicine.

J Anesth. 2012 Oct;26(5):650-7. doi: 10.1007/s00540-012-1402-x. Epub 2012 May 23.

4.

Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.

Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N, Forrest P, Gattas D, Granger E, Herkes R, Jackson A, McGuinness S, Nair P, Pellegrino V, Pettilä V, Plunkett B, Pye R, Torzillo P, Webb S, Wilson M, Ziegenfuss M.

JAMA. 2009 Nov 4;302(17):1888-95. doi: 10.1001/jama.2009.1535. Epub 2009 Oct 12.

PMID:
19822628
5.

Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A.

Turner DA, Rehder KJ, Peterson-Carmichael SL, Ozment CP, Al-Hegelan MS, Williford WL, Peters MA, Noble PW, Cheifetz IM.

Respir Care. 2011 Jul;56(7):941-6. doi: 10.4187/respcare.01066. Epub 2011 Feb 21.

6.

Experience with high frequency oscillation ventilation during the 2009 H1N1 influenza pandemic in Australia and New Zealand.

Boots RJ, Lipman J, Lassig-Smith M, Stephens DP, Thomas J, Shehabi Y, Bass F, Anthony A, Long D, Seppelt IM, Weisbrodt L, Erickson S, Beca J, Sherring C, McGuiness S, Parke R, Stachowski ER, Boyd R, Howet B.

Anaesth Intensive Care. 2011 Sep;39(5):837-46.

7.
8.

[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].

Rodríguez A, Alvarez-Rocha L, Sirvent JM, Zaragoza R, Nieto M, Arenzana A, Luque P, Socías L, Martín M, Navarro D, Camarena J, Lorente L, Trefler S, Vidaur L, Solé-Violán J, Barcenilla F, Pobo A, Vallés J, Ferri C, Martín-Loeches I, Díaz E, López D, López-Pueyo MJ, Gordo F, del Nogal F, Marqués A, Tormo S, Fuset MP, Pérez F, Bonastre J, Suberviola B, Navas E, León C; GETGAG; Infectious Diseases Work Group (GTEI) of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC); Infections in Critically Ill Patients Study Group (GEIPC) of Spanish Society of Infectious Diseases and Clinical Microbiology.

Med Intensiva. 2012 Mar;36(2):103-37. doi: 10.1016/j.medin.2011.11.020. Epub 2012 Jan 13. Spanish.

9.

A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection.

Ruggiero T, De Rosa F, Cerutti F, Pagani N, Allice T, Stella ML, Milia MG, Calcagno A, Burdino E, Gregori G, Urbino R, Di Perri G, Ranieri MV, Ghisetti V.

Influenza Other Respir Viruses. 2013 Nov;7(6):1416-26. doi: 10.1111/irv.12146. Epub 2013 Aug 9.

10.

Extracorporeal membrane oxygenation for severe influenza A (H1N1) acute respiratory distress syndrome: a prospective observational comparative study.

Roch A, Lepaul-Ercole R, Grisoli D, Bessereau J, Brissy O, Castanier M, Dizier S, Forel JM, Guervilly C, Gariboldi V, Collart F, Michelet P, Perrin G, Charrel R, Papazian L.

Intensive Care Med. 2010 Nov;36(11):1899-905. doi: 10.1007/s00134-010-2021-3. Epub 2010 Aug 19.

PMID:
20721530
11.

Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome: single-centre experience with 1-year follow-up.

Beurtheret S, Mastroianni C, Pozzi M, D'Alessandro C, Luyt CE, Combes A, Pavie A, Leprince P.

Eur J Cardiothorac Surg. 2012 Mar;41(3):691-5. doi: 10.1093/ejcts/ezr082. Epub 2012 Jan 6.

PMID:
22228837
12.

Extracorporeal membrane oxygenation for pandemic H1N1 2009 respiratory failure.

Holzgraefe B, Broomé M, Kalzén H, Konrad D, Palmér K, Frenckner B.

Minerva Anestesiol. 2010 Dec;76(12):1043-51.

13.

Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza.

Lemaitre F, Luyt CE, Roullet-Renoleau F, Nieszkowska A, Zahr N, Corvol E, Fernandez C, Antignac M, Farinotti R, Combes A.

Ther Drug Monit. 2012 Apr;34(2):171-5. doi: 10.1097/FTD.0b013e318248672c.

PMID:
22354159
14.

[Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome caused by novel 2009 influenza A (H1N1) virus].

Zhan QY, Sun B, Tong ZH, Guo LM, Xu L, Zhu X, Jia XJ, Wang C.

Zhonghua Yi Xue Za Zhi. 2011 Dec 13;91(46):3262-6. Chinese.

PMID:
22333146
15.

Clinical review: Extracorporeal membrane oxygenation.

Gattinoni L, Carlesso E, Langer T.

Crit Care. 2011;15(6):243. doi: 10.1186/cc10490. Epub 2011 Dec 8. Review.

16.

Extra-corporeal membrane oxygenation in the management of 2009 influenza A (H1N1) refractory respiratory failure.

Das JP, Chew N, Kitt E, Murphy C, O'Rourke J, Power M, McConkey SJ.

Ir Med J. 2011 Mar;104(3):90-1.

PMID:
21667616
17.

A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic.

Mitchell MD, Mikkelsen ME, Umscheid CA, Lee I, Fuchs BD, Halpern SD.

Crit Care Med. 2010 Jun;38(6):1398-404. doi: 10.1097/CCM.0b013e3181de45db. Review.

18.

Extracorporeal membrane oxygenation for critically ill patients with 2009 influenza A (H1N1)-related acute respiratory distress syndrome: preliminary experience from a single center.

Hou X, Guo L, Zhan Q, Jia X, Mi Y, Li B, Sun B, Hao X, Li H.

Artif Organs. 2012 Sep;36(9):780-6. doi: 10.1111/j.1525-1594.2012.01468.x. Epub 2012 Jul 2.

PMID:
22747918
19.

[The use of extracorporeal membrane oxygenation (ECMO) in the treatment of acute respiratory distress syndrome due to pandemic influenza].

Knapik P, Przybylski R, Nadziakiewicz P, Koba R, Maciejewski T, Borowicz M, Włoczka G, Pawlak S, Zembala M.

Kardiol Pol. 2011;69(4):416-20. Polish.

20.

Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis.

Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, Mourvillier B, Ara-Somohano C, Bastien O, Zogheib E, Clavel M, Constan A, Marie Richard JC, Brun-Buisson C, Brochard L; REVA Research Network.

Am J Respir Crit Care Med. 2013 Feb 1;187(3):276-85. doi: 10.1164/rccm.201205-0815OC. Epub 2012 Nov 15.

PMID:
23155145
Items per page

Supplemental Content

Write to the Help Desk